Lariam, also known by its generic name mefloquine, is a prescription medication primarily used for the prevention and treatment of malaria, a potentially life-threatening disease caused by parasites transmitted through the bite of infected mosquitoes. Lariam belongs to the class of drugs called antimalarials and works by interfering with the growth and reproduction of the malaria parasites in the body.
In terms of prevention, Lariam is commonly prescribed for individuals planning to travel or reside in areas where malaria is prevalent, particularly those regions where the parasites have become resistant to other antimalarial medications. It is usually taken orally once a week, starting a few weeks before arriving in the malaria-endemic area, during the stay, and for several weeks after leaving. It is crucial to strictly follow the prescribed dosage and schedule for optimal effectiveness.
Lariam is also used for the treatment of uncomplicated malaria caused by specific malaria parasites. The duration and dosage will vary depending on the severity of the infection and individual circumstances, as determined by a healthcare professional.
As with any medication, Lariam may cause certain side effects, such as headache, dizziness, nausea, vomiting, sleep disturbances, or mood changes. Rarely, it can lead to more serious adverse reactions, including psychiatric symptoms or neurologic effects. It is vital to inform the prescribing healthcare professional of any pre-existing medical conditions, medications, or allergies before starting Lariam to ensure its safe and appropriate use.
Overall, Lariam is a widely used antimalarial drug that plays a crucial role in the prevention and treatment of malaria, especially in regions where other medications may not be as effective.
